The rapid evolution in the pharmaceutical sector has made drug development more complex, with shorter timelines and high-end regulatory expectations worldwide. In that strict environment, many pharma companies are increasing their reliance on external partners for drug manufacturing. This is …
The unexpected evolution in the pharma sector has driven rapid growth through new technologies, regulatory changes, and global demand. All such approaches have transformed the pharmaceutical industry, as companies are no longer just producing medicines. In fact, we are focused …
Among the most highly regulated industries, the pharmaceutical sector is globally recognised. Each drug that reaches the patient needs to pass strict safety, quality, and efficacy checks. It’s where the Regulatory Services Pharma plays an important role. The regulatory services …
The new year brings new resolutions and opportunities, like improved health and commitment to the adoption of healthy habits. These intentions sound good and impressive, but focusing on them throughout the year is a major challenge for many. What of …
With the development of advanced technology, the healthcare sector has seen significant growth. Earlier, medications were developed under a one-drug-for-everyone approach, but that’s no longer the case. Doctors ensured to give the same treatment to multiple patients in the hope …
Getting fresh expectations is what every new year brings among individuals, brands, and industries. Talking about healthcare, oncology has seen a rapid development and demand—this shift is of maintaining higher standards, which is getting more serious than ever. In recent …
Oncology drug manufacturing in India is shaping the future of global cancer treatment. With rising cancer cases worldwide, the demand for effective and affordable oncology medicines is increasing rapidly. India has emerged as a trusted hub for oncology drug development, …
With the expansion of the global oncology market, there is increasing demand for precision due to rising cancer incidence and the rapid adoption of targeted therapies, biologics, and complex injectables. This is necessary because pharmaceutical companies are always under immense …
